ECOG 0 4 0 4 B-clinical_variable
Performance 5 16 5 16 I-clinical_variable
Status 17 23 17 23 I-clinical_variable
0 24 25 24 25 B-lower_bound
- 25 26 25 26 O
1 26 27 26 27 B-upper_bound

Intermediate 0 12 28 40 O
risk 13 17 41 45 O
: 17 18 45 46 O
Gleason 18 25 46 53 B-clinical_variable
< 26 27 54 55 O
or=6 27 31 55 59 O
& 32 33 60 61 O
PSA 34 37 62 65 B-clinical_variable
< 37 38 65 66 O
or=10 38 43 66 71 O
& 44 45 72 73 O
Clinical 46 54 74 82 B-clinical_variable
Stage 55 60 83 88 I-clinical_variable
T2b 61 64 89 92 I-clinical_variable
OR 65 67 93 95 O
Gleason=7 68 77 96 105 O
& 78 79 106 107 O
PSA 80 83 108 111 O
< 83 84 111 112 O
or=10 84 89 112 117 O
& 90 91 118 119 O
Clinical 92 100 120 128 B-clinical_variable
Stage 101 106 129 134 I-clinical_variable
T1b 107 110 135 138 I-clinical_variable
- 110 111 138 139 I-clinical_variable
T2b 111 114 139 142 I-clinical_variable
OR 115 117 143 145 O
Gleason 118 125 146 153 O
< 126 127 154 155 O
or=6 127 131 155 159 O
& 132 133 160 161 O
PSA 134 137 162 165 O
> 138 139 166 167 O
10 140 142 168 170 O
& 143 144 171 172 O
< 145 146 173 174 O
or 147 149 175 177 O
= 150 151 178 179 O
20 151 153 179 181 B-upper_bound
& 154 155 182 183 O
Clinical 156 164 184 192 O
Stage 165 170 193 198 O
T1b- 171 175 199 203 O
T2b 176 179 204 207 O
, 179 180 207 208 O
Nx 181 183 209 211 O
or 184 186 212 214 O
NO 187 189 215 217 O
, 189 190 217 218 O
Mx 191 193 219 221 O
or 194 196 222 224 O
M0 197 199 225 227 O

Low 0 3 228 231 O
risk 4 8 232 236 O
: 8 9 236 237 O
Gleason 10 17 238 245 B-clinical_variable
< 18 19 246 247 O
or=6 19 23 247 251 O
& 24 25 252 253 O
PSA 26 29 254 257 B-clinical_variable
< 30 31 258 259 O
or=10 31 36 259 264 O
& 37 38 265 266 O
Clinical 39 47 267 275 O
Stage 48 53 276 281 O
T1b 54 57 282 285 B-lower_bound
- 57 58 285 286 O
T2a 58 61 286 289 B-upper_bound
, 61 62 289 290 O
Nx 62 64 290 292 B-cancer
or 65 67 293 295 O
N0 68 70 296 298 O
, 70 71 298 299 O
Mx 72 74 300 302 B-cancer
or 75 77 303 305 O
M0 78 80 306 308 B-cancer

No 0 2 309 311 O
prior 3 8 312 317 B-treatment
prostate 9 17 318 326 I-treatment
radiation 18 27 327 336 I-treatment
or 28 30 337 339 O
other 31 36 340 345 O
definitive 37 47 346 356 B-treatment
therapy 48 55 357 364 I-treatment

chemotherapy 0 12 365 377 B-treatment
for 13 16 378 381 O
a 17 18 382 383 O
malignancy 19 29 384 394 B-cancer
within 30 36 395 401 O
the 37 40 402 405 O
previous 41 49 406 414 B-upper_bound
5 50 51 415 416 I-upper_bound
years 52 57 417 422 I-upper_bound

histologically 0 14 423 437 O
proven 15 21 438 444 O
prostate 22 30 445 453 B-cancer
adenocarcinoma 31 45 454 468 I-cancer
within 46 52 469 475 O
1 53 54 476 477 B-upper_bound
year 55 59 478 482 I-upper_bound
of 60 62 483 485 O
enrollment 63 73 486 496 O

history 0 7 497 504 O
of 8 10 505 507 O
an 11 13 508 510 O
invasive 14 22 511 519 B-cancer
malignancy 23 33 520 530 I-cancer
( 34 35 531 532 O
other 35 40 532 537 O
than 41 45 538 542 O
this 46 50 543 547 O
prostate 51 59 548 556 B-cancer
cancer 60 66 557 563 I-cancer
, 66 67 563 564 O
or 67 69 564 566 O
basal 70 75 567 572 B-cancer
or 76 78 573 575 I-cancer
squamous 79 87 576 584 I-cancer
skin 88 92 585 589 I-cancer
cancers 93 100 590 597 I-cancer
) 100 101 597 598 O
within 102 108 599 605 O
prior 109 114 606 611 B-upper_bound
5 115 116 612 613 I-upper_bound
years 117 122 614 619 I-upper_bound

hormone 0 7 620 627 B-treatment
ablation 8 16 628 636 I-treatment
for 17 20 637 640 O
2 21 22 641 642 B-upper_bound
months 23 29 643 649 I-upper_bound
prior 30 35 650 655 I-upper_bound
to 36 38 656 658 O
treatment 39 48 659 668 O
or 49 51 669 671 O
during 52 58 672 678 O
treatment 59 68 679 688 O

implanted 0 9 689 698 O
hardware 10 18 699 707 O
or 19 21 708 710 O
other 22 27 711 716 O
material 28 36 717 725 O
that 37 41 726 730 O
would 42 47 731 736 O
prohibit 48 56 737 745 O
treatment 57 66 746 755 B-treatment
planning 67 75 756 764 O
or 76 78 765 767 O
delivery 79 87 768 776 O

